

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 8.23067623 |
| 2 | actin-myosin filament sliding (GO:0033275) | 8.23067623 |
| 3 | actin-mediated cell contraction (GO:0070252) | 7.11512334 |
| 4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.99367012 |
| 5 | regulation of skeletal muscle contraction (GO:0014819) | 6.75839792 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 6.12002748 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.12002748 |
| 8 | skeletal muscle contraction (GO:0003009) | 6.05774873 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 5.87800282 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.87800282 |
| 11 | actin filament-based movement (GO:0030048) | 5.42993210 |
| 12 | aromatic amino acid family catabolic process (GO:0009074) | 5.26727398 |
| 13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.25970221 |
| 14 | myofibril assembly (GO:0030239) | 5.23418789 |
| 15 | lysine catabolic process (GO:0006554) | 5.05011496 |
| 16 | lysine metabolic process (GO:0006553) | 5.05011496 |
| 17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.99748517 |
| 18 | glyoxylate metabolic process (GO:0046487) | 4.98827239 |
| 19 | response to muscle activity (GO:0014850) | 4.91131595 |
| 20 | kynurenine metabolic process (GO:0070189) | 4.86480162 |
| 21 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.85720180 |
| 22 | regulation of relaxation of muscle (GO:1901077) | 4.74753410 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 4.74598545 |
| 24 | sarcomere organization (GO:0045214) | 4.67867112 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.58742006 |
| 26 | cardiac myofibril assembly (GO:0055003) | 4.55765083 |
| 27 | indole-containing compound catabolic process (GO:0042436) | 4.54369706 |
| 28 | indolalkylamine catabolic process (GO:0046218) | 4.54369706 |
| 29 | tryptophan catabolic process (GO:0006569) | 4.54369706 |
| 30 | skeletal muscle fiber development (GO:0048741) | 4.53696406 |
| 31 | striated muscle contraction (GO:0006941) | 4.53405536 |
| 32 | creatine metabolic process (GO:0006600) | 4.44810415 |
| 33 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.44022140 |
| 34 | tryptophan metabolic process (GO:0006568) | 4.40799183 |
| 35 | 2-oxoglutarate metabolic process (GO:0006103) | 4.37266834 |
| 36 | cellular ketone body metabolic process (GO:0046950) | 4.36863444 |
| 37 | bile acid biosynthetic process (GO:0006699) | 4.36794655 |
| 38 | estrogen biosynthetic process (GO:0006703) | 4.35805055 |
| 39 | protein carboxylation (GO:0018214) | 4.34568503 |
| 40 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.34568503 |
| 41 | plasma membrane repair (GO:0001778) | 4.32660465 |
| 42 | fatty acid beta-oxidation (GO:0006635) | 4.20869260 |
| 43 | urea metabolic process (GO:0019627) | 4.19270081 |
| 44 | urea cycle (GO:0000050) | 4.19270081 |
| 45 | negative regulation of fibrinolysis (GO:0051918) | 4.18893818 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.18008205 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 4.17619928 |
| 48 | sulfur amino acid catabolic process (GO:0000098) | 4.17479726 |
| 49 | response to inactivity (GO:0014854) | 4.15412318 |
| 50 | myotube cell development (GO:0014904) | 4.14372108 |
| 51 | complement activation, alternative pathway (GO:0006957) | 4.14202625 |
| 52 | high-density lipoprotein particle remodeling (GO:0034375) | 4.12713916 |
| 53 | regulation of fibrinolysis (GO:0051917) | 4.05503310 |
| 54 | cysteine metabolic process (GO:0006534) | 4.04943222 |
| 55 | aspartate family amino acid catabolic process (GO:0009068) | 4.01307865 |
| 56 | triglyceride homeostasis (GO:0070328) | 4.01111056 |
| 57 | acylglycerol homeostasis (GO:0055090) | 4.01111056 |
| 58 | muscle contraction (GO:0006936) | 3.98131094 |
| 59 | homocysteine metabolic process (GO:0050667) | 3.97372279 |
| 60 | fatty acid transmembrane transport (GO:1902001) | 3.96781771 |
| 61 | fatty acid oxidation (GO:0019395) | 3.94551376 |
| 62 | serine family amino acid catabolic process (GO:0009071) | 3.93717559 |
| 63 | regulation of protein activation cascade (GO:2000257) | 3.93185115 |
| 64 | actomyosin structure organization (GO:0031032) | 3.89024237 |
| 65 | myoblast fusion (GO:0007520) | 3.88573362 |
| 66 | alpha-amino acid catabolic process (GO:1901606) | 3.87876760 |
| 67 | bile acid metabolic process (GO:0008206) | 3.87417347 |
| 68 | fatty acid catabolic process (GO:0009062) | 3.86785211 |
| 69 | nitrogen cycle metabolic process (GO:0071941) | 3.86386578 |
| 70 | carnitine shuttle (GO:0006853) | 3.86084154 |
| 71 | lipid oxidation (GO:0034440) | 3.85833960 |
| 72 | glycogen catabolic process (GO:0005980) | 3.84965110 |
| 73 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.84798273 |
| 74 | tyrosine metabolic process (GO:0006570) | 3.83146025 |
| 75 | aromatic amino acid family metabolic process (GO:0009072) | 3.82926528 |
| 76 | short-chain fatty acid metabolic process (GO:0046459) | 3.81700295 |
| 77 | phospholipid homeostasis (GO:0055091) | 3.80939604 |
| 78 | negative regulation of protein localization to cell surface (GO:2000009) | 3.80621744 |
| 79 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.78698277 |
| 80 | ketone body metabolic process (GO:1902224) | 3.74307392 |
| 81 | monocarboxylic acid catabolic process (GO:0072329) | 3.73882090 |
| 82 | reverse cholesterol transport (GO:0043691) | 3.72976395 |
| 83 | acetyl-CoA metabolic process (GO:0006084) | 3.70960427 |
| 84 | valine metabolic process (GO:0006573) | 3.70844091 |
| 85 | muscle cell fate commitment (GO:0042693) | 3.66685419 |
| 86 | regulation of complement activation (GO:0030449) | 3.66267189 |
| 87 | cellular amino acid catabolic process (GO:0009063) | 3.62253475 |
| 88 | coenzyme catabolic process (GO:0009109) | 3.59872414 |
| 89 | plasma lipoprotein particle clearance (GO:0034381) | 3.59196754 |
| 90 | phospholipid efflux (GO:0033700) | 3.57687912 |
| 91 | protein-lipid complex remodeling (GO:0034368) | 3.56951668 |
| 92 | macromolecular complex remodeling (GO:0034367) | 3.56951668 |
| 93 | plasma lipoprotein particle remodeling (GO:0034369) | 3.56951668 |
| 94 | carnitine metabolic process (GO:0009437) | 3.54794282 |
| 95 | glucan catabolic process (GO:0009251) | 3.53800574 |
| 96 | muscle system process (GO:0003012) | 3.53323578 |
| 97 | cellular modified amino acid catabolic process (GO:0042219) | 3.50759613 |
| 98 | 4-hydroxyproline metabolic process (GO:0019471) | 3.48518910 |
| 99 | organic acid catabolic process (GO:0016054) | 3.47105973 |
| 100 | carboxylic acid catabolic process (GO:0046395) | 3.47105973 |
| 101 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.46945931 |
| 102 | regulation of cholesterol esterification (GO:0010872) | 3.45678679 |
| 103 | cardiac muscle contraction (GO:0060048) | 3.45124303 |
| 104 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.42825844 |
| 105 | bile acid and bile salt transport (GO:0015721) | 3.42120792 |
| 106 | positive regulation of fatty acid oxidation (GO:0046321) | 3.41786158 |
| 107 | cellular polysaccharide catabolic process (GO:0044247) | 3.41127288 |
| 108 | ethanol oxidation (GO:0006069) | 3.40929508 |
| 109 | positive regulation of lipid catabolic process (GO:0050996) | 3.40827598 |
| 110 | skeletal muscle tissue regeneration (GO:0043403) | 3.39284355 |
| 111 | tricarboxylic acid metabolic process (GO:0072350) | 3.38534018 |
| 112 | regulation of sequestering of triglyceride (GO:0010889) | 3.37493228 |
| 113 | indolalkylamine metabolic process (GO:0006586) | 3.36005779 |
| 114 | glutamate metabolic process (GO:0006536) | 3.35912283 |
| 115 | benzene-containing compound metabolic process (GO:0042537) | 3.32643537 |
| 116 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.32411031 |
| 117 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.32284496 |
| 118 | negative regulation of cholesterol transport (GO:0032375) | 3.31899858 |
| 119 | negative regulation of sterol transport (GO:0032372) | 3.31899858 |
| 120 | branched-chain amino acid catabolic process (GO:0009083) | 3.31324417 |
| 121 | regulation of cholesterol homeostasis (GO:2000188) | 3.31193899 |
| 122 | muscle fiber development (GO:0048747) | 3.30113394 |
| 123 | skeletal muscle tissue development (GO:0007519) | 3.28474032 |
| 124 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.28019578 |
| 125 | negative regulation of lipase activity (GO:0060192) | 3.27349030 |
| 126 | regulation of fatty acid oxidation (GO:0046320) | 3.23335733 |
| 127 | branched-chain amino acid metabolic process (GO:0009081) | 3.21405572 |
| 128 | intestinal cholesterol absorption (GO:0030299) | 3.21390787 |
| 129 | regulation of cell communication by electrical coupling (GO:0010649) | 3.21030035 |
| 130 | oxaloacetate metabolic process (GO:0006107) | 3.17712015 |
| 131 | drug catabolic process (GO:0042737) | 3.16204770 |
| 132 | drug transmembrane transport (GO:0006855) | 3.15134246 |
| 133 | cellular glucuronidation (GO:0052695) | 3.14692741 |
| 134 | cholesterol homeostasis (GO:0042632) | 3.13340299 |
| 135 | skeletal muscle adaptation (GO:0043501) | 3.12440003 |
| 136 | fatty acid homeostasis (GO:0055089) | 3.12347678 |
| 137 | syncytium formation (GO:0006949) | 3.11549195 |
| 138 | cholesterol efflux (GO:0033344) | 3.09484359 |
| 139 | sterol homeostasis (GO:0055092) | 3.08951363 |
| 140 | regulation of bile acid biosynthetic process (GO:0070857) | 3.07554805 |
| 141 | tricarboxylic acid cycle (GO:0006099) | 3.06855473 |
| 142 | carnitine transmembrane transport (GO:1902603) | 3.06770175 |
| 143 | polysaccharide catabolic process (GO:0000272) | 3.03404710 |
| 144 | glucan biosynthetic process (GO:0009250) | 3.01399573 |
| 145 | glycogen biosynthetic process (GO:0005978) | 3.01399573 |
| 146 | cardiac muscle hypertrophy (GO:0003300) | 3.00932271 |
| 147 | regulation of actin filament-based movement (GO:1903115) | 3.00111008 |
| 148 | myotube differentiation (GO:0014902) | 2.99963401 |
| 149 | paraxial mesoderm development (GO:0048339) | 2.99667933 |
| 150 | muscle tissue morphogenesis (GO:0060415) | 2.96774217 |
| 151 | regulation of myoblast differentiation (GO:0045661) | 2.91112550 |
| 152 | striated muscle hypertrophy (GO:0014897) | 2.87179517 |
| 153 | response to follicle-stimulating hormone (GO:0032354) | 2.86954954 |
| 154 | muscle structure development (GO:0061061) | 2.85614813 |
| 155 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.84686428 |
| 156 | muscle organ development (GO:0007517) | 2.80273152 |
| 157 | positive regulation of myoblast differentiation (GO:0045663) | 2.77763385 |
| 158 | muscle cell cellular homeostasis (GO:0046716) | 2.76612079 |
| 159 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.75739716 |
| 160 | cardiac muscle cell development (GO:0055013) | 2.73691491 |
| 161 | striated muscle cell development (GO:0055002) | 2.72214701 |
| 162 | lymph vessel development (GO:0001945) | 2.71847492 |
| 163 | striated muscle adaptation (GO:0014888) | 2.69428386 |
| 164 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.67575900 |
| 165 | glycogen metabolic process (GO:0005977) | 2.67111790 |
| 166 | cardiac cell development (GO:0055006) | 2.63936565 |
| 167 | positive regulation of myotube differentiation (GO:0010831) | 2.62951632 |
| 168 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.61691487 |
| 169 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.61598731 |
| 170 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.61342422 |
| 171 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.61342422 |
| 172 | regulation of striated muscle contraction (GO:0006942) | 2.61311673 |
| 173 | glucan metabolic process (GO:0044042) | 2.59207242 |
| 174 | cellular glucan metabolic process (GO:0006073) | 2.59207242 |
| 175 | glucocorticoid biosynthetic process (GO:0006704) | 2.59001392 |
| 176 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.58323091 |
| 177 | response to activity (GO:0014823) | 2.58025078 |
| 178 | relaxation of muscle (GO:0090075) | 2.57929877 |
| 179 | neuronal action potential propagation (GO:0019227) | 2.55674310 |
| 180 | adult heart development (GO:0007512) | 2.55658349 |
| 181 | regulation of lipoprotein metabolic process (GO:0050746) | 2.50684408 |
| 182 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.48430762 |
| 183 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.48430762 |
| 184 | regulation of skeletal muscle fiber development (GO:0048742) | 2.46573381 |
| 185 | muscle organ morphogenesis (GO:0048644) | 2.44939661 |
| 186 | hippo signaling (GO:0035329) | 2.44363249 |
| 187 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.44262313 |
| 188 | muscle cell development (GO:0055001) | 2.41415530 |
| 189 | muscle hypertrophy (GO:0014896) | 2.38629996 |
| 190 | blood coagulation, intrinsic pathway (GO:0007597) | 2.38057633 |
| 191 | fructose metabolic process (GO:0006000) | 2.36208320 |
| 192 | regulation of protein localization to cell surface (GO:2000008) | 2.36099733 |
| 193 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.34608452 |
| 194 | striated muscle tissue development (GO:0014706) | 2.33664747 |
| 195 | negative regulation of norepinephrine secretion (GO:0010700) | 2.32715422 |
| 196 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.31650157 |
| 197 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.28440976 |
| 198 | regulation of muscle system process (GO:0090257) | 2.28050922 |
| 199 | muscle hypertrophy in response to stress (GO:0003299) | 2.27283270 |
| 200 | cardiac muscle adaptation (GO:0014887) | 2.27283270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.53135088 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.87897075 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.99163123 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.64689328 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.53526154 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.70443025 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.67968670 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.85445274 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.58534498 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.89392632 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.76569319 |
| 12 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.72031932 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.66689615 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.54796544 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.44501029 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.22608972 |
| 17 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.11126794 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.07073913 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.03048465 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.01665357 |
| 21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.84381010 |
| 22 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.76817015 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.72604190 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.67282079 |
| 25 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.64581695 |
| 26 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.64367508 |
| 27 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.64367508 |
| 28 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.62817040 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.60026345 |
| 30 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57290587 |
| 31 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.56893655 |
| 32 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.53034853 |
| 33 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.52578981 |
| 34 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.52269490 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51927836 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.50454957 |
| 37 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.49757290 |
| 38 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.49757290 |
| 39 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.41769030 |
| 40 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.39924632 |
| 41 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.36397431 |
| 42 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.35682845 |
| 43 | CJUN_26792858_Chip-Seq_BT549_Human | 1.35413857 |
| 44 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.35352481 |
| 45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33734538 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33428268 |
| 47 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.31907515 |
| 48 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31144847 |
| 49 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30892414 |
| 50 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.28948020 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28008238 |
| 52 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.27950893 |
| 53 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.26155550 |
| 54 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.25752097 |
| 55 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.25587694 |
| 56 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.24457660 |
| 57 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.23781908 |
| 58 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19837208 |
| 59 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.17446396 |
| 60 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.16679154 |
| 61 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.16074107 |
| 62 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.15639862 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12493236 |
| 64 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11627823 |
| 65 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.11490968 |
| 66 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.11045640 |
| 67 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.10838749 |
| 68 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.08361973 |
| 69 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.07087611 |
| 70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06679846 |
| 71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06009224 |
| 72 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05912664 |
| 73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05819371 |
| 74 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04689420 |
| 75 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.04384823 |
| 76 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03915530 |
| 77 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.03898317 |
| 78 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.02386982 |
| 79 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.02362649 |
| 80 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.01915747 |
| 81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01629295 |
| 82 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.99672597 |
| 83 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99426018 |
| 84 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99357425 |
| 85 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97960199 |
| 86 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97857900 |
| 87 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96564581 |
| 88 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.95887492 |
| 89 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.95201837 |
| 90 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94533482 |
| 91 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.94314841 |
| 92 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93396851 |
| 93 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.93330755 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93135318 |
| 95 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92857141 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92256738 |
| 97 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92175953 |
| 98 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.91936111 |
| 99 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.91734712 |
| 100 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.90394357 |
| 101 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.90261185 |
| 102 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.90084899 |
| 103 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89989713 |
| 104 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89550257 |
| 105 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85729241 |
| 106 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85525194 |
| 107 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82352512 |
| 108 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81103296 |
| 109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80976699 |
| 110 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80726451 |
| 111 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80352928 |
| 112 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79811785 |
| 113 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.78967475 |
| 114 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78605341 |
| 115 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75959957 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75959957 |
| 117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.75896087 |
| 118 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.74563671 |
| 119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73834908 |
| 120 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.73641847 |
| 121 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73603669 |
| 122 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72913266 |
| 123 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.72553370 |
| 124 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.71674313 |
| 125 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.71648251 |
| 126 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.71174994 |
| 127 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.68193849 |
| 128 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.67642379 |
| 129 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.64948715 |
| 130 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.62090728 |
| 131 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.60935123 |
| 132 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.60506874 |
| 133 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.60069026 |
| 134 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.59716319 |
| 135 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.59540678 |
| 136 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.58711148 |
| 137 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.58676605 |
| 138 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.57448460 |
| 139 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.57369553 |
| 140 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.57261113 |
| 141 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.57060479 |
| 142 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.56561753 |
| 143 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.55937541 |
| 144 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.55551017 |
| 145 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.54687720 |
| 146 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.54520448 |
| 147 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.54016281 |
| 148 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.53857902 |
| 149 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.53376519 |
| 150 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53271696 |
| 151 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.53221582 |
| 152 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.52828772 |
| 153 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52764553 |
| 154 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.52659672 |
| 155 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.52280899 |
| 156 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52141589 |
| 157 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.51303482 |
| 158 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.51177130 |
| 159 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.50625560 |
| 160 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.50347531 |
| 161 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.49864449 |
| 162 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.49404957 |
| 163 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.48643679 |
| 164 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48435400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.21227082 |
| 2 | MP0005360_urolithiasis | 5.37340581 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.07324938 |
| 4 | MP0005365_abnormal_bile_salt | 4.99794703 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 4.23211910 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.69842002 |
| 7 | MP0003252_abnormal_bile_duct | 3.51322294 |
| 8 | MP0003195_calcinosis | 3.27907867 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.97285449 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.78511004 |
| 11 | MP0005083_abnormal_biliary_tract | 2.65106210 |
| 12 | MP0009840_abnormal_foam_cell | 2.58068474 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.53751546 |
| 14 | MP0004272_abnormal_basement_membrane | 2.35397932 |
| 15 | MP0004084_abnormal_cardiac_muscle | 2.33293121 |
| 16 | MP0003646_muscle_fatigue | 2.30369745 |
| 17 | MP0004233_abnormal_muscle_weight | 2.28241574 |
| 18 | MP0005332_abnormal_amino_acid | 2.25881192 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.19340366 |
| 20 | MP0005670_abnormal_white_adipose | 2.15740410 |
| 21 | MP0002108_abnormal_muscle_morphology | 2.12801891 |
| 22 | MP0000733_abnormal_muscle_development | 2.02829337 |
| 23 | MP0004130_abnormal_muscle_cell | 1.96751671 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.93115605 |
| 25 | MP0004036_abnormal_muscle_relaxation | 1.92303795 |
| 26 | MP0002332_abnormal_exercise_endurance | 1.89999465 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.84746793 |
| 28 | MP0004215_abnormal_myocardial_fiber | 1.83816419 |
| 29 | MP0003941_abnormal_skin_development | 1.80655597 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.80493288 |
| 31 | MP0000609_abnormal_liver_physiology | 1.79866451 |
| 32 | MP0005330_cardiomyopathy | 1.76566141 |
| 33 | MP0000751_myopathy | 1.71028895 |
| 34 | MP0003868_abnormal_feces_composition | 1.64744064 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.63491353 |
| 36 | MP0001879_abnormal_lymphatic_vessel | 1.57952509 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.49115053 |
| 38 | MP0003950_abnormal_plasma_membrane | 1.45203897 |
| 39 | MP0002078_abnormal_glucose_homeostasis | 1.44797137 |
| 40 | MP0004019_abnormal_vitamin_homeostasis | 1.44282537 |
| 41 | MP0000749_muscle_degeneration | 1.43492251 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.43357438 |
| 43 | MP0005666_abnormal_adipose_tissue | 1.43312690 |
| 44 | MP0010030_abnormal_orbit_morphology | 1.43278690 |
| 45 | MP0003122_maternal_imprinting | 1.39358102 |
| 46 | MP0004043_abnormal_pH_regulation | 1.39181837 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 1.38769990 |
| 48 | MP0002972_abnormal_cardiac_muscle | 1.31466334 |
| 49 | MP0003385_abnormal_body_wall | 1.28727628 |
| 50 | MP0002269_muscular_atrophy | 1.27371453 |
| 51 | MP0008004_abnormal_stomach_pH | 1.27336985 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 1.27094218 |
| 53 | MP0004087_abnormal_muscle_fiber | 1.25989409 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.22530605 |
| 55 | MP0005451_abnormal_body_composition | 1.22522505 |
| 56 | MP0005275_abnormal_skin_tensile | 1.21820855 |
| 57 | MP0008775_abnormal_heart_ventricle | 1.20643048 |
| 58 | MP0001544_abnormal_cardiovascular_syste | 1.17155406 |
| 59 | MP0005385_cardiovascular_system_phenoty | 1.17155406 |
| 60 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.16706640 |
| 61 | MP0002909_abnormal_adrenal_gland | 1.16541620 |
| 62 | MP0005220_abnormal_exocrine_pancreas | 1.16383579 |
| 63 | MP0010630_abnormal_cardiac_muscle | 1.15413524 |
| 64 | MP0002693_abnormal_pancreas_physiology | 1.12948466 |
| 65 | MP0001299_abnormal_eye_distance/ | 1.11808978 |
| 66 | MP0006138_congestive_heart_failure | 1.10718827 |
| 67 | MP0005620_abnormal_muscle_contractility | 1.08993317 |
| 68 | MP0001764_abnormal_homeostasis | 1.08896849 |
| 69 | MP0000534_abnormal_ureter_morphology | 1.08035961 |
| 70 | MP0006276_abnormal_autonomic_nervous | 1.08022896 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 1.07050344 |
| 72 | MP0001944_abnormal_pancreas_morphology | 1.06730950 |
| 73 | MP0009250_abnormal_appendicular_skeleto | 1.06167134 |
| 74 | MP0003566_abnormal_cell_adhesion | 1.05184177 |
| 75 | MP0002128_abnormal_blood_circulation | 1.02369186 |
| 76 | MP0005503_abnormal_tendon_morphology | 1.00189693 |
| 77 | MP0005464_abnormal_platelet_physiology | 1.00016474 |
| 78 | MP0003137_abnormal_impulse_conducting | 0.99857029 |
| 79 | MP0004270_analgesia | 0.98117106 |
| 80 | MP0003942_abnormal_urinary_system | 0.96894645 |
| 81 | MP0005375_adipose_tissue_phenotype | 0.96825154 |
| 82 | MP0005535_abnormal_body_temperature | 0.96273780 |
| 83 | MP0002971_abnormal_brown_adipose | 0.94139290 |
| 84 | MP0009697_abnormal_copulation | 0.94108427 |
| 85 | MP0005334_abnormal_fat_pad | 0.94071729 |
| 86 | MP0000598_abnormal_liver_morphology | 0.93505649 |
| 87 | MP0004185_abnormal_adipocyte_glucose | 0.93449721 |
| 88 | MP0002896_abnormal_bone_mineralization | 0.91720485 |
| 89 | MP0004085_abnormal_heartbeat | 0.90501173 |
| 90 | MP0001958_emphysema | 0.88317681 |
| 91 | MP0000230_abnormal_systemic_arterial | 0.88038114 |
| 92 | MP0000750_abnormal_muscle_regeneration | 0.87486162 |
| 93 | MP0005623_abnormal_meninges_morphology | 0.86138860 |
| 94 | MP0009642_abnormal_blood_homeostasis | 0.85103620 |
| 95 | MP0000266_abnormal_heart_morphology | 0.84857264 |
| 96 | MP0004134_abnormal_chest_morphology | 0.84632424 |
| 97 | MP0003279_aneurysm | 0.84443782 |
| 98 | MP0005636_abnormal_mineral_homeostasis | 0.83577910 |
| 99 | MP0000013_abnormal_adipose_tissue | 0.83459038 |
| 100 | MP0004510_myositis | 0.81804765 |
| 101 | MP0002106_abnormal_muscle_physiology | 0.81506922 |
| 102 | MP0002928_abnormal_bile_duct | 0.79466273 |
| 103 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78538289 |
| 104 | MP0005171_absent_coat_pigmentation | 0.78132120 |
| 105 | MP0001756_abnormal_urination | 0.77534586 |
| 106 | MP0000747_muscle_weakness | 0.76773166 |
| 107 | MP0005266_abnormal_metabolism | 0.75395890 |
| 108 | MP0005647_abnormal_sex_gland | 0.74025705 |
| 109 | MP0003186_abnormal_redox_activity | 0.73709735 |
| 110 | MP0003953_abnormal_hormone_level | 0.73249565 |
| 111 | MP0009763_increased_sensitivity_to | 0.72561491 |
| 112 | MP0005448_abnormal_energy_balance | 0.71304371 |
| 113 | MP0000767_abnormal_smooth_muscle | 0.70144614 |
| 114 | MP0008961_abnormal_basal_metabolism | 0.69423656 |
| 115 | MP0003283_abnormal_digestive_organ | 0.67673810 |
| 116 | MP0006054_spinal_hemorrhage | 0.67474486 |
| 117 | MP0005409_darkened_coat_color | 0.67181871 |
| 118 | MP0003879_abnormal_hair_cell | 0.66861111 |
| 119 | MP0002697_abnormal_eye_size | 0.66846841 |
| 120 | MP0002127_abnormal_cardiovascular_syste | 0.66772098 |
| 121 | MP0003656_abnormal_erythrocyte_physiolo | 0.66510904 |
| 122 | MP0005369_muscle_phenotype | 0.66399262 |
| 123 | MP0001661_extended_life_span | 0.66300771 |
| 124 | MP0005084_abnormal_gallbladder_morpholo | 0.66290826 |
| 125 | MP0003828_pulmonary_edema | 0.64400395 |
| 126 | MP0000762_abnormal_tongue_morphology | 0.63388492 |
| 127 | MP0001765_abnormal_ion_homeostasis | 0.63155781 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.63134498 |
| 129 | MP0000003_abnormal_adipose_tissue | 0.62352957 |
| 130 | MP0000759_abnormal_skeletal_muscle | 0.61925052 |
| 131 | MP0001915_intracranial_hemorrhage | 0.60657392 |
| 132 | MP0002114_abnormal_axial_skeleton | 0.60427448 |
| 133 | MP0004484_altered_response_of | 0.60284069 |
| 134 | MP0006035_abnormal_mitochondrial_morpho | 0.60122517 |
| 135 | MP0002233_abnormal_nose_morphology | 0.60001674 |
| 136 | MP0003935_abnormal_craniofacial_develop | 0.59257344 |
| 137 | MP0004145_abnormal_muscle_electrophysio | 0.58560239 |
| 138 | MP0002234_abnormal_pharynx_morphology | 0.57891300 |
| 139 | MP0001614_abnormal_blood_vessel | 0.57769915 |
| 140 | MP0008469_abnormal_protein_level | 0.56860053 |
| 141 | MP0005376_homeostasis/metabolism_phenot | 0.56051125 |
| 142 | MP0000428_abnormal_craniofacial_morphol | 0.55204567 |
| 143 | MP0000049_abnormal_middle_ear | 0.54902887 |
| 144 | MP0005187_abnormal_penis_morphology | 0.54888808 |
| 145 | MP0005165_increased_susceptibility_to | 0.54349644 |
| 146 | MP0009703_decreased_birth_body | 0.52301656 |
| 147 | MP0003300_gastrointestinal_ulcer | 0.52137674 |
| 148 | MP0005595_abnormal_vascular_smooth | 0.51777255 |
| 149 | MP0008789_abnormal_olfactory_epithelium | 0.50956240 |
| 150 | MP0001293_anophthalmia | 0.50837528 |
| 151 | MP0003091_abnormal_cell_migration | 0.50762985 |
| 152 | MP0003959_abnormal_lean_body | 0.49987797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 9.17465078 |
| 2 | Nemaline bodies (HP:0003798) | 9.08853016 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.76949799 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 7.27331399 |
| 5 | Hypoglycemic coma (HP:0001325) | 5.77249834 |
| 6 | Distal arthrogryposis (HP:0005684) | 5.53099838 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.47919861 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 5.17480140 |
| 9 | Deep venous thrombosis (HP:0002625) | 5.16794897 |
| 10 | Ketosis (HP:0001946) | 4.88146199 |
| 11 | Ketoacidosis (HP:0001993) | 4.84904795 |
| 12 | Xanthomatosis (HP:0000991) | 4.81556409 |
| 13 | Round ear (HP:0100830) | 4.64281065 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.56145039 |
| 15 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.52569296 |
| 16 | Myopathic facies (HP:0002058) | 4.32492507 |
| 17 | Prolonged partial thromboplastin time (HP:0003645) | 4.30361012 |
| 18 | Ulnar deviation of the wrist (HP:0003049) | 4.26324951 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 4.07093068 |
| 20 | Hypoglycemic seizures (HP:0002173) | 4.06306817 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 4.04775948 |
| 22 | Calcaneovalgus deformity (HP:0001848) | 3.98541166 |
| 23 | Hypobetalipoproteinemia (HP:0003563) | 3.97441035 |
| 24 | Hyperammonemia (HP:0001987) | 3.94986156 |
| 25 | Abnormality of the calf musculature (HP:0001430) | 3.92272875 |
| 26 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.85781997 |
| 27 | Rimmed vacuoles (HP:0003805) | 3.79167506 |
| 28 | Complement deficiency (HP:0004431) | 3.78540619 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.72238261 |
| 30 | Hyperglycinuria (HP:0003108) | 3.66615516 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 3.63554178 |
| 32 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.62151345 |
| 33 | Neck muscle weakness (HP:0000467) | 3.57321315 |
| 34 | Hypolipoproteinemia (HP:0010981) | 3.54627478 |
| 35 | Abnormality of the common coagulation pathway (HP:0010990) | 3.53241626 |
| 36 | Sudden death (HP:0001699) | 3.52247364 |
| 37 | Deformed tarsal bones (HP:0008119) | 3.50195710 |
| 38 | Myoglobinuria (HP:0002913) | 3.49289736 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 3.47233145 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.44536402 |
| 41 | Epidermoid cyst (HP:0200040) | 3.43890556 |
| 42 | Hyperglycinemia (HP:0002154) | 3.43062487 |
| 43 | Hyperglycemia (HP:0003074) | 3.42718023 |
| 44 | Increased variability in muscle fiber diameter (HP:0003557) | 3.41685727 |
| 45 | Absent phalangeal crease (HP:0006109) | 3.41281412 |
| 46 | Abnormality of glycine metabolism (HP:0010895) | 3.38093799 |
| 47 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.38093799 |
| 48 | Difficulty running (HP:0009046) | 3.36764479 |
| 49 | Generalized aminoaciduria (HP:0002909) | 3.33953073 |
| 50 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.25966560 |
| 51 | Late onset (HP:0003584) | 3.23541048 |
| 52 | Ventricular tachycardia (HP:0004756) | 3.19547693 |
| 53 | Skin nodule (HP:0200036) | 3.14979008 |
| 54 | Myotonia (HP:0002486) | 3.12534715 |
| 55 | Increased connective tissue (HP:0009025) | 3.12170640 |
| 56 | Conjugated hyperbilirubinemia (HP:0002908) | 3.11948608 |
| 57 | Dicarboxylic aciduria (HP:0003215) | 3.11893194 |
| 58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.11893194 |
| 59 | Joint hemorrhage (HP:0005261) | 3.10369165 |
| 60 | Symptomatic seizures (HP:0011145) | 3.02945475 |
| 61 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.99553238 |
| 62 | Distal lower limb muscle weakness (HP:0009053) | 2.99533316 |
| 63 | Right ventricular cardiomyopathy (HP:0011663) | 2.97124556 |
| 64 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.90403873 |
| 65 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.89281138 |
| 66 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.88472220 |
| 67 | Gout (HP:0001997) | 2.83921434 |
| 68 | Fat malabsorption (HP:0002630) | 2.82098182 |
| 69 | Muscle stiffness (HP:0003552) | 2.82064182 |
| 70 | Abnormal finger flexion creases (HP:0006143) | 2.81370826 |
| 71 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.77415716 |
| 72 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.77415716 |
| 73 | Malignant hyperthermia (HP:0002047) | 2.77306413 |
| 74 | Abnormality of methionine metabolism (HP:0010901) | 2.77200252 |
| 75 | Areflexia of lower limbs (HP:0002522) | 2.75007419 |
| 76 | Metabolic acidosis (HP:0001942) | 2.73324594 |
| 77 | Abnormality of purine metabolism (HP:0004352) | 2.73123589 |
| 78 | Asymmetric septal hypertrophy (HP:0001670) | 2.72998119 |
| 79 | Exercise-induced myalgia (HP:0003738) | 2.71003951 |
| 80 | Palpitations (HP:0001962) | 2.70600693 |
| 81 | Hyperbilirubinemia (HP:0002904) | 2.69991304 |
| 82 | Frequent falls (HP:0002359) | 2.69910881 |
| 83 | Abnormality of complement system (HP:0005339) | 2.69098486 |
| 84 | Spinal rigidity (HP:0003306) | 2.68754446 |
| 85 | Hypercholesterolemia (HP:0003124) | 2.67072270 |
| 86 | Abnormality of the calcaneus (HP:0008364) | 2.65302620 |
| 87 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.64022686 |
| 88 | Calf muscle hypertrophy (HP:0008981) | 2.62474977 |
| 89 | Cerebral edema (HP:0002181) | 2.56814277 |
| 90 | Abnormality of nucleobase metabolism (HP:0010932) | 2.48409034 |
| 91 | Protrusio acetabuli (HP:0003179) | 2.47657855 |
| 92 | Exercise-induced muscle cramps (HP:0003710) | 2.45997802 |
| 93 | Lipoatrophy (HP:0100578) | 2.42089322 |
| 94 | Hip contracture (HP:0003273) | 2.41944020 |
| 95 | Scapular winging (HP:0003691) | 2.41410829 |
| 96 | EMG: neuropathic changes (HP:0003445) | 2.41334076 |
| 97 | Generalized muscle weakness (HP:0003324) | 2.40868079 |
| 98 | Hyporeflexia of lower limbs (HP:0002600) | 2.40794714 |
| 99 | Atrial fibrillation (HP:0005110) | 2.38702565 |
| 100 | Distal lower limb amyotrophy (HP:0008944) | 2.38195178 |
| 101 | Atrioventricular block (HP:0001678) | 2.38191668 |
| 102 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.36885766 |
| 103 | Abnormality of serum amino acid levels (HP:0003112) | 2.35538986 |
| 104 | Abnormal gallbladder morphology (HP:0012437) | 2.34662440 |
| 105 | Rhabdomyolysis (HP:0003201) | 2.33239858 |
| 106 | Bundle branch block (HP:0011710) | 2.33021769 |
| 107 | Lethargy (HP:0001254) | 2.31013605 |
| 108 | Syncope (HP:0001279) | 2.29434694 |
| 109 | Slender build (HP:0001533) | 2.27397204 |
| 110 | Dilated cardiomyopathy (HP:0001644) | 2.26850174 |
| 111 | Delayed CNS myelination (HP:0002188) | 2.25484958 |
| 112 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.25219947 |
| 113 | Cholelithiasis (HP:0001081) | 2.24501527 |
| 114 | Menorrhagia (HP:0000132) | 2.23790347 |
| 115 | Gowers sign (HP:0003391) | 2.21901686 |
| 116 | Proximal tubulopathy (HP:0000114) | 2.20698866 |
| 117 | Hepatocellular carcinoma (HP:0001402) | 2.20502440 |
| 118 | Limited hip movement (HP:0008800) | 2.20339588 |
| 119 | Muscle fiber splitting (HP:0003555) | 2.19823729 |
| 120 | Myocardial infarction (HP:0001658) | 2.17744884 |
| 121 | Heart block (HP:0012722) | 2.16736457 |
| 122 | Aortic aneurysm (HP:0004942) | 2.16373978 |
| 123 | Primary atrial arrhythmia (HP:0001692) | 2.13969941 |
| 124 | Limb-girdle muscle atrophy (HP:0003797) | 2.12230989 |
| 125 | Fetal akinesia sequence (HP:0001989) | 2.09769693 |
| 126 | Hepatic necrosis (HP:0002605) | 2.06958948 |
| 127 | Renal cortical cysts (HP:0000803) | 2.06020900 |
| 128 | Vomiting (HP:0002013) | 2.04535135 |
| 129 | Glycosuria (HP:0003076) | 2.03435783 |
| 130 | Abnormality of urine glucose concentration (HP:0011016) | 2.03435783 |
| 131 | Subaortic stenosis (HP:0001682) | 2.03029533 |
| 132 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.03029533 |
| 133 | Weak cry (HP:0001612) | 2.02583775 |
| 134 | Abnormal atrioventricular conduction (HP:0005150) | 2.00848933 |
| 135 | Insulin resistance (HP:0000855) | 2.00730528 |
| 136 | Supraventricular tachycardia (HP:0004755) | 2.00494941 |
| 137 | Systemic lupus erythematosus (HP:0002725) | 2.00455677 |
| 138 | Abnormality of the ischium (HP:0003174) | 2.00020395 |
| 139 | Increased mean platelet volume (HP:0011877) | 1.99619790 |
| 140 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.98979926 |
| 141 | Mitral stenosis (HP:0001718) | 1.97070769 |
| 142 | Supraventricular arrhythmia (HP:0005115) | 1.97048640 |
| 143 | Hyperuricemia (HP:0002149) | 1.96483686 |
| 144 | Increased purine levels (HP:0004368) | 1.96483686 |
| 145 | Large for gestational age (HP:0001520) | 1.96389572 |
| 146 | Pancreatitis (HP:0001733) | 1.93905684 |
| 147 | Back pain (HP:0003418) | 1.93693944 |
| 148 | Lower limb amyotrophy (HP:0007210) | 1.88675009 |
| 149 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.87907081 |
| 150 | Waddling gait (HP:0002515) | 1.86037491 |
| 151 | Bulbar palsy (HP:0001283) | 1.85881831 |
| 152 | Fatigable weakness (HP:0003473) | 1.85551168 |
| 153 | Abnormality of the neuromuscular junction (HP:0003398) | 1.85551168 |
| 154 | Difficulty climbing stairs (HP:0003551) | 1.85422618 |
| 155 | Aortic dissection (HP:0002647) | 1.84160023 |
| 156 | Popliteal pterygium (HP:0009756) | 1.81768292 |
| 157 | Premature rupture of membranes (HP:0001788) | 1.80007499 |
| 158 | Long clavicles (HP:0000890) | 1.79016926 |
| 159 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.78922830 |
| 160 | Muscular dystrophy (HP:0003560) | 1.78204840 |
| 161 | Hyperkalemia (HP:0002153) | 1.78067773 |
| 162 | Vascular tortuosity (HP:0004948) | 1.77536681 |
| 163 | Limb-girdle muscle weakness (HP:0003325) | 1.77107457 |
| 164 | Arterial tortuosity (HP:0005116) | 1.75850509 |
| 165 | Ulnar deviation of finger (HP:0009465) | 1.75178386 |
| 166 | Metatarsus adductus (HP:0001840) | 1.68880493 |
| 167 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.68843707 |
| 168 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.68843707 |
| 169 | Hypoplastic ischia (HP:0003175) | 1.66507418 |
| 170 | Proximal amyotrophy (HP:0007126) | 1.66400799 |
| 171 | Abnormality of the foot musculature (HP:0001436) | 1.65591652 |
| 172 | Hypoplasia of the iris (HP:0007676) | 1.63921699 |
| 173 | Abnormal platelet volume (HP:0011876) | 1.63305515 |
| 174 | Shoulder girdle muscle weakness (HP:0003547) | 1.63210752 |
| 175 | Foot dorsiflexor weakness (HP:0009027) | 1.55902718 |
| 176 | Pelvic girdle muscle weakness (HP:0003749) | 1.55159710 |
| 177 | Thin ribs (HP:0000883) | 1.48799369 |
| 178 | Adducted thumb (HP:0001181) | 1.47391684 |
| 179 | Breech presentation (HP:0001623) | 1.47040504 |
| 180 | Cerebral aneurysm (HP:0004944) | 1.46278233 |
| 181 | Prolonged bleeding time (HP:0003010) | 1.46190804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.95180833 |
| 2 | INSRR | 4.79726210 |
| 3 | ERN1 | 3.24476857 |
| 4 | TRIB3 | 3.15695854 |
| 5 | PKN2 | 2.97825682 |
| 6 | TTN | 2.97727419 |
| 7 | SIK1 | 2.87997468 |
| 8 | TAOK3 | 2.63931320 |
| 9 | FGFR4 | 2.31904225 |
| 10 | PDK4 | 2.17731391 |
| 11 | PDK3 | 2.17731391 |
| 12 | LATS2 | 2.15902604 |
| 13 | FLT3 | 2.11208053 |
| 14 | OBSCN | 1.91091430 |
| 15 | MYLK | 1.73273116 |
| 16 | TIE1 | 1.72571827 |
| 17 | PINK1 | 1.70657595 |
| 18 | PHKG2 | 1.68993339 |
| 19 | PHKG1 | 1.68993339 |
| 20 | MAPK15 | 1.62002125 |
| 21 | LATS1 | 1.59168966 |
| 22 | PTK6 | 1.54043238 |
| 23 | FRK | 1.49766000 |
| 24 | LMTK2 | 1.46185490 |
| 25 | WNK4 | 1.44038897 |
| 26 | AKT3 | 1.40428604 |
| 27 | NME1 | 1.40014755 |
| 28 | EPHB2 | 1.39835008 |
| 29 | PRKD3 | 1.29058575 |
| 30 | TGFBR2 | 1.28330158 |
| 31 | DDR2 | 1.26861514 |
| 32 | MARK1 | 1.25244229 |
| 33 | PIK3CA | 1.24588061 |
| 34 | PIK3CG | 1.23678535 |
| 35 | PRKAA2 | 1.20825556 |
| 36 | PDGFRA | 1.18073374 |
| 37 | NEK9 | 1.16687894 |
| 38 | PDK2 | 1.16363801 |
| 39 | PRKAA1 | 1.10266613 |
| 40 | STK38L | 1.08917909 |
| 41 | PAK3 | 1.07916394 |
| 42 | IRAK3 | 1.05112823 |
| 43 | MAP2K3 | 1.04789880 |
| 44 | EEF2K | 1.04355901 |
| 45 | TRPM7 | 1.03509427 |
| 46 | RIPK1 | 1.01743007 |
| 47 | EPHA3 | 0.96626424 |
| 48 | MAP3K3 | 0.95104219 |
| 49 | MAP3K7 | 0.94060492 |
| 50 | PRKD1 | 0.92278355 |
| 51 | MAPK11 | 0.91149162 |
| 52 | JAK1 | 0.90933316 |
| 53 | PASK | 0.90099664 |
| 54 | CAMK1D | 0.89431710 |
| 55 | MAP3K1 | 0.88279035 |
| 56 | JAK2 | 0.86195081 |
| 57 | DMPK | 0.86178961 |
| 58 | KDR | 0.85332037 |
| 59 | MAP2K4 | 0.83282661 |
| 60 | STK3 | 0.82560443 |
| 61 | NTRK1 | 0.80807737 |
| 62 | EPHB1 | 0.79925863 |
| 63 | MAP3K10 | 0.79855585 |
| 64 | ERBB4 | 0.79811537 |
| 65 | ERBB3 | 0.76594886 |
| 66 | TNIK | 0.76284524 |
| 67 | BMX | 0.75986177 |
| 68 | MST1R | 0.75286011 |
| 69 | MUSK | 0.73310399 |
| 70 | TYK2 | 0.73138543 |
| 71 | HIPK2 | 0.72858276 |
| 72 | CAMK2G | 0.71381730 |
| 73 | PTK2B | 0.69987330 |
| 74 | DYRK1B | 0.69686727 |
| 75 | AKT2 | 0.67190079 |
| 76 | CDC42BPA | 0.66033082 |
| 77 | CAMK1G | 0.65919210 |
| 78 | SGK3 | 0.65410157 |
| 79 | MAP3K5 | 0.64652367 |
| 80 | PRKACG | 0.64041524 |
| 81 | FGFR3 | 0.63011257 |
| 82 | GRK7 | 0.62730004 |
| 83 | MET | 0.61650240 |
| 84 | IRAK1 | 0.61025435 |
| 85 | PRKCH | 0.60363247 |
| 86 | MOS | 0.60103617 |
| 87 | ICK | 0.59279482 |
| 88 | PAK2 | 0.58550849 |
| 89 | CAMK4 | 0.58193606 |
| 90 | RET | 0.58130860 |
| 91 | MTOR | 0.56980243 |
| 92 | CAMK2D | 0.56877837 |
| 93 | PRKG1 | 0.56832278 |
| 94 | MAPK12 | 0.56068334 |
| 95 | STK39 | 0.55803183 |
| 96 | PDGFRB | 0.55409601 |
| 97 | PNCK | 0.53796159 |
| 98 | PTK2 | 0.53772909 |
| 99 | PLK2 | 0.53520218 |
| 100 | TBK1 | 0.53252753 |
| 101 | SGK2 | 0.50343583 |
| 102 | DAPK2 | 0.50316931 |
| 103 | STK24 | 0.47809155 |
| 104 | LIMK1 | 0.46058459 |
| 105 | PDPK1 | 0.45490268 |
| 106 | MAP3K2 | 0.45418159 |
| 107 | NEK1 | 0.43647159 |
| 108 | PKN1 | 0.43622000 |
| 109 | GSK3A | 0.43096649 |
| 110 | BRD4 | 0.43069681 |
| 111 | DAPK3 | 0.42949263 |
| 112 | KSR2 | 0.40754540 |
| 113 | TYRO3 | 0.40664841 |
| 114 | SGK223 | 0.37523367 |
| 115 | SGK494 | 0.37523367 |
| 116 | ILK | 0.37483498 |
| 117 | FER | 0.36296461 |
| 118 | ABL2 | 0.35520706 |
| 119 | WNK3 | 0.35029697 |
| 120 | EIF2AK1 | 0.34805306 |
| 121 | MAPKAPK3 | 0.34177780 |
| 122 | IGF1R | 0.33823774 |
| 123 | CAMK1 | 0.33354851 |
| 124 | CAMK2A | 0.33354005 |
| 125 | IRAK2 | 0.32625615 |
| 126 | RPS6KA2 | 0.32479388 |
| 127 | PDK1 | 0.31985466 |
| 128 | ROCK2 | 0.31378427 |
| 129 | PRKACB | 0.31365809 |
| 130 | PRKD2 | 0.31295339 |
| 131 | ERBB2 | 0.31020446 |
| 132 | FGFR2 | 0.30542857 |
| 133 | PRKACA | 0.30236723 |
| 134 | STK38 | 0.29726482 |
| 135 | ROCK1 | 0.29097838 |
| 136 | CAMK2B | 0.27824404 |
| 137 | SGK1 | 0.27515898 |
| 138 | FGFR1 | 0.26684780 |
| 139 | PRKCE | 0.26502117 |
| 140 | MARK2 | 0.26477005 |
| 141 | PRKCZ | 0.26415146 |
| 142 | RPS6KA3 | 0.25918234 |
| 143 | MAP2K1 | 0.25865333 |
| 144 | MAPK7 | 0.24792589 |
| 145 | RPS6KC1 | 0.24672041 |
| 146 | RPS6KL1 | 0.24672041 |
| 147 | MAPK10 | 0.22867746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.60582054 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.43994965 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.04424265 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.86874869 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.74325801 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.73745000 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73663779 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.66233456 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.65472689 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.60729630 |
| 11 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.49907769 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.49163817 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.35954478 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.29844778 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.26485635 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.23508850 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.22312487 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.10632404 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95025988 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.93246424 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.89142600 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.84344226 |
| 23 | Focal adhesion_Homo sapiens_hsa04510 | 1.78207083 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.67899409 |
| 25 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.66711608 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64912048 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.64245121 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64208391 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.59238476 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55963765 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53515162 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.51392860 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49975233 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.47015784 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.44449831 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.43567873 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.40139322 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.39286066 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.36779926 |
| 40 | Adherens junction_Homo sapiens_hsa04520 | 1.36166007 |
| 41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.33724163 |
| 42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.31663064 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31370903 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.31298282 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.28038176 |
| 46 | Tight junction_Homo sapiens_hsa04530 | 1.26622945 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.25499264 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.25438364 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23541815 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.21544374 |
| 51 | Retinol metabolism_Homo sapiens_hsa00830 | 1.17907586 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.17649915 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16681975 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 1.16545410 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.15314202 |
| 56 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.14648466 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10696821 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.05659927 |
| 59 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.03609880 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97670279 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.95265987 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.95209849 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94780496 |
| 64 | Gap junction_Homo sapiens_hsa04540 | 0.92045984 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91778484 |
| 66 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.90697616 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.86111894 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.84377217 |
| 69 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.84312032 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.83867334 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83294312 |
| 72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.81276917 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.80457015 |
| 74 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77704350 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.75963981 |
| 76 | Axon guidance_Homo sapiens_hsa04360 | 0.75498128 |
| 77 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73528695 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73303973 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72394448 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70877875 |
| 81 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.70061851 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67123587 |
| 83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66845342 |
| 84 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.65846932 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65821904 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64953254 |
| 87 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64570245 |
| 88 | Melanogenesis_Homo sapiens_hsa04916 | 0.61443796 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.61011633 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60356329 |
| 91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60316791 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59393116 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59118562 |
| 94 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.59004122 |
| 95 | Long-term depression_Homo sapiens_hsa04730 | 0.57771034 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57625326 |
| 97 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.57077169 |
| 98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55665054 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55357917 |
| 100 | Glioma_Homo sapiens_hsa05214 | 0.52961966 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52950130 |
| 102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52202137 |
| 103 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51940553 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51851554 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50653010 |
| 106 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.50143497 |
| 107 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.49252496 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49046710 |
| 109 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47954783 |
| 110 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47623184 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47564593 |
| 112 | Circadian entrainment_Homo sapiens_hsa04713 | 0.47142953 |
| 113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45825171 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44461008 |
| 115 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44449036 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44106901 |
| 117 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43215180 |
| 118 | Long-term potentiation_Homo sapiens_hsa04720 | 0.43069299 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42488113 |
| 120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41615981 |
| 121 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.41289501 |
| 122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.38843078 |
| 123 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.38224371 |
| 124 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37854757 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37716389 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37442275 |
| 127 | Prion diseases_Homo sapiens_hsa05020 | 0.33941273 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32977093 |
| 129 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32816873 |
| 130 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31757711 |
| 131 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29214523 |
| 132 | Insulin secretion_Homo sapiens_hsa04911 | 0.27559378 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26974046 |
| 134 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.26328117 |
| 135 | Protein export_Homo sapiens_hsa03060 | 0.25838889 |
| 136 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21207219 |
| 137 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.20069114 |
| 138 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.19011456 |
| 139 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.15748479 |
| 140 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.14801365 |
| 141 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.11446201 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10448965 |
| 143 | Circadian rhythm_Homo sapiens_hsa04710 | 0.09401108 |
| 144 | Parkinsons disease_Homo sapiens_hsa05012 | 0.08860251 |
| 145 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.08349523 |
| 146 | Alzheimers disease_Homo sapiens_hsa05010 | 0.08013888 |
| 147 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.02634129 |
| 148 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.01297966 |
| 149 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0127967 |

